Cedars Sinai Intellectual Property Company | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

28,336 results for “Cedars Sinai Intellectual Property Company”

Trials

View all 7162 →

The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study

1,000 participants · First posted Apr 10, 2019

Personalized Cancer Care at Cedars-Sinai Medical Center Samuel Oschin Comprehensive Cancer Institute

52 participants · First posted Apr 4, 2017

Increasing HPV Vaccination Rates Via Educational Interventions in Schools Located Within Cedars-Sinai Catchment Areas

3 participants · First posted May 17, 2019

Drugs

View all 134 →

iPSC therapy (Cedars-Sinai Medical Center)

CNS10-NPC(Cedars-Sinai Medical Center)

HerDox

Organizations

View all 1675 →

Oxthera Intellectual Property AB

Sweden

Cedars-Sinai Health System

United States

CEDARS-SINAI MEDICAL CENTER

United States

News

View all 19365 →

Cirrus Therapeutics Secures $14.7M Seed Financing and SERI Collaboration to Advance Ocular Gene Therapy for Geographic Atrophy

Kazia Therapeutics Sells Cantrixil Intellectual Property Rights to Vivesto for $1 Million

Cedars-Sinai Partners with Oxford Science Enterprises to Advance Digital Health Innovation, Invests $2M in AI-Powered Neurology Platform

Page 1 of 2834